Editorial | Independent drug approvals are key to Hong Kong’s biotech ambitions
- Posted on July 5, 2026
- By South China Morning Post
- 0 Views
- 1 min read
Editorial | Independent drug approvals are key to Hong Kong’s biotech ambitions
Moving to a primary evaluation system will let the city directly approve innovative drugs based on local and international trial data.
